SCHEMBL7738490

SCHEMBL7738490

CC1OC(C)C(C)C(=O)C1C

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
ATM Q13315 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15369786 0.73
SCHEMBL19275893 0.71
SCHEMBL19251741 0.71
SCHEMBL19277878 0.71
SCHEMBL17525227 0.71
SCHEMBL19251731 0.71
SCHEMBL16204346 0.69
SCHEMBL3691291 0.67 ATM (0.33) SMN1; SMN2ALDH1A1MAPTATMNPSR1
SCHEMBL2349091 0.67 ATM (0.33) SMN1; SMN2ALDH1A1MAPTATMNPSR1
SCHEMBL19251729 0.67 ATM (0.33) ALDH1A1MAPTATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120054342-A Tray cleaning agent filling system of methanol-to-olefin device 宁夏宝丰能源集团股份有限公司 2025-05-30 CN claimed
CN-120054342-A Tray cleaning agent filling system of methanol-to-olefin device 宁夏宝丰能源集团股份有限公司 2025-05-30 CN disclosed
US-20100137320-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION 2010-06-03 US disclosed
US-20100137320-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION 2010-06-03 US disclosed
US-5414173-A Process of preparing cyclopentadiene and substituted derivatives thereof THE DOW CHEMICAL COMPANY (US) 1995-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137320-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, GSAP SMN1; SMN2 1408/4885ALDH1A1 1823/4885MAPT 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.